🇬🇧 Rimegepant for acute migraine treatment in United Kingdom

Rimegepant for acute migraine treatment (rimegepant-for-acute-migraine-treatment) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: approved

Rimegepant for acute migraine treatment in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United Kingdom

Frequently asked questions

Is Rimegepant for acute migraine treatment approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Rimegepant for acute migraine treatment in United Kingdom?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.